Supporting national and regional pharmacovigilance and vaccine surveillance processes.
VigiFlow is a management system for recording, processing and sharing reports of adverse effects
VigiFlow supports the domestic collection and processing of individual case safety report (ICSR) data, and its sharing of reports with for example VigiBase. It permits maximum local control and provides effective means for management review and analysis of national data.
UMC provides general guidance on what and how to capture adverse event reports for COVID-19 treatments.
VigiFlow is evolving to provide more efficient reporting of adverse events following immunisation (AEFI) and better meet the needs of vaccine safety surveillance.